前瞻性多阅片者评估光子计数CT用于多发性骨髓瘤筛查
本研究前瞻性纳入7例意义未明的单克隆丙种球蛋白病患者,同日行标准能量积分探测器CT与光子计数CT全身非增强扫描,7名放射科医生对5个轴位层面图像评分。结果显示两种采集方式的骨皮质与骨小梁清晰度、图像噪声及诊断信心评分相似,光子计数CT检出的溶骨性病灶比例更高(79% vs 64%),且辐射剂量更低。
要点
- 光子计数CT与能量积分探测器CT的骨皮质、骨小梁清晰度及图像噪声评分无显著差异。
- 光子计数CT检出溶骨性病灶的比例为79%(22/28),能量积分探测器CT为64%(18/28)。
- 光子计数CT的容积CT剂量指数为1.8 ± 0.6,能量积分探测器CT为11.37 ± 2.8(P = .06)。
核心结论
- 这项先导性研究提示,光子计数CT在显著更低的辐射剂量下,可提供与能量积分探测器CT相似的定量和定性评分。
研究设计与样本
- 前瞻性研究,纳入7例意义未明的单克隆丙种球蛋白病患者(4例女性,平均年龄66岁±9[标准差],体重指数30.1 kg/m2±5.2),同日行临床非增强全身CT(能量积分探测器)与光子计数CT扫描,扫描时间为2021年8月至12月。
关键影像表现/征象
- 骨皮质清晰度评分:能量积分探测器CT为83,光子计数CT为84(P = .65)。
- 骨小梁清晰度评分:能量积分探测器CT为67,光子计数CT为66(P = .11)。
- 图像噪声评分:能量积分探测器CT为75,光子计数CT为74(P = .26)。
- 图像质量评分:能量积分探测器CT为78,光子计数CT为76(P = .11)。
- 两种采集方式的对比噪声比和信噪比相似。
诊断标准与关键数值
- 7名放射科医生对5个轴位层面图像进行评分,其中11%(8/70)的图像包含溶骨性病灶。
- 图像以随机顺序展示,每名阅片者评估骨皮质与骨小梁清晰度、感知图像噪声水平及诊断信心,并标注是否存在溶骨性病灶。
- 光子计数CT检出溶骨性病灶的比例为79%(22/28),能量积分探测器CT为64%(18/28)。
- 容积CT剂量指数:能量积分探测器CT为11.37 ± 2.8,光子计数CT为1.8 ± 0.6(P = .06)。
- 剂量长度乘积:能量积分探测器CT为1654.1 ± 409.6,光子计数CT为253.4 ± 89.6(P = .05)。
临床应用与阅片要点
- 本研究为光子计数CT用于多发性骨髓瘤筛查的先导性研究,作者在结论中指出光子计数CT可在显著更低的辐射剂量下提供与能量积分探测器CT相似的定量和定性评分。
局限性
- 本文为先导性研究,样本量小,仅纳入7例患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Purpose To determine whether photon-counting CT (PCCT) acquisition of whole-body CT images provides similar quantitative image quality and reader satisfaction for multiple myeloma screening at lower radiation doses than does standard energy-integrating detector (EID) CT. Materials and Methods Patients with monoclonal gammopathy of undetermined significance prospectively underwent clinical noncontrast whole-body CT with EID and same-day PCCT (August-December 2021). Five axial scan locations were evaluated by seven radiologists, with 11% (eight of 70) of images including osteolytic lesions. Images were shown in randomized order, and each reader rated the following: discernibility of the osseous cortex and osseous trabeculae, perceived image noise level, and diagnostic confidence. Presence of lytic osseous lesions was indicated. Contrast-to-noise ratio (CNR) and signal-to-noise ratio (SNR) were calculated. Comparisons were made using paired t tests and mixed linear effects models. Results Seven participants (four women) were included (mean age, 66 years ± 9 [SD]; body mass index, 30.1 kg/m2 ± 5.2). Mean cortical definition, trabecular definition, image noise, and image quality scores were 83, 67, 75, and 78 versus 84, 66, 74, and 76 for EID and PCCT, respectively (P = .65, .11, .26, and .11, respectively). PCCT helped identify more lesions (79% [22 of 28]) than did EID (64% [18 of 28]). CNRs and SNRs were similar between modalities. PCCT had lower radiation doses than EID (volume CT dose index: EID, 11.37 ± 2.8 vs PCCT, 1.8 ± 0.6 [P = .06]; dose-length product: EID, 1654.1 ± 409.6 vs PCCT, 253.4 ± 89.6 [P = .05]). Conclusion This pilot investigation suggests that PCCT affords similar quantitative and qualitative scores as EID at significantly lower radiation doses. Keywords: CT, CT-Spectral, Skeletal-Axial, Spine, Hematologic Diseases, Whole-Body Imaging, Comparative Studies Supplemental material is available for this article. © RSNA, 2022.
引用
- Schwartz FR, Vinson EN, Spritzer CE, et al. Prospective Multireader Evaluation of Photon-counting CT for Multiple Myeloma Screening. Radiol Imaging Cancer. 2022. PMID: 36399038. doi:10.1148/rycan.220073
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。